According to Vision Research Reports, the global pharmaceutical testing and analytical services market size surpassed at US$ 3.6 Bn in 2019 and to reach US$ 10.4 billion by 2027 with a CAGR of 10% from 2021 to 2027.
Rise in the number of clinical trials is a major factor boosting the market. The number of clinical trials being conducted globally has been increasing significantly for the past few years. Rise in the number of clinical trials is being driven by a surge in the demand for innovative solutions in the healthcare industry, owing to technological advancements in the industry. For instance, in 2018, 293,341 active clinical trials were carried out for the design and development of new products.
Pharmaceutical testing and quality assurance are important stages in the pharmaceutical industry. Testing and analysis are carried out as people’s lives depend on the quality and quantity measure of a given medicine. Bioanalytical testing, method development & validation, raw material testing, stability testing, and microbial testing are commonly employed tests adopted in pharmaceutical and medical devices industries. The expansion of the global pharmaceutical testing and analytical services market can be ascribed to rise in the number of clinical trials and increase in R&D spending.
North America dominated the global pharmaceutical testing and analytical services market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players who are focused on design and development of new treatment options for the treatment of major chronic diseases is likely to further drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global pharmaceutical testing and analytical services market. It is projected to expand at a rapid pace during the forecast period.
Rise in Number of Clinical Trials and Increase in R&D Spending to Drive Global Market
The increase in the number of clinical trials is projected to boost the pharmaceutical testing and analytical services market. Rising prevalence of cancer is a key factor driving the number of clinical trials being conducted. Furthermore, it is estimated that the number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. Increase in R&D spending and focus of biopharmaceutical companies on boosting revenues has propelled the pharmaceutical testing and analytical services market.
Inorganic growth is a key strategy adopted by major players operating in the pharmaceutical testing and analytical services market in order to consolidate their position in the market. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market. These factors are estimated to propel the pharmaceutical testing and analytical services market during the forecast period.
Bioanalytical Testing Segment to Dominate Global Market
Based on service type, the global pharmaceutical testing and analytical services market has been divided into bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further segmented into cell-based assays, virology testing, and others. The method development & validation segment has been sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. The raw material testing segment has been split into heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others. The bioanalytical testing segment dominated the global pharmaceutical testing and analytical services market in 2019. This trend is projected to continue during the forecast period.
The increase in use of cell-based assay, virology, and other tests in drug development is likely boost the bioanalytical testing segment during the forecast period. Cell-based assays have been a key component in streamlining the drug development process, helping drugs to be introduced in the market in a rapid and efficient manner.
The method development & validation segment was followed by the bioanalytical testing segment, in terms of market share, in 2019.
Pharmaceutical & Biopharmaceutical Companies to Offer Lucrative Opportunities
In terms of end user, the global pharmaceutical testing and analytical services market has been split into medical device companies, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical companies segment accounted for a prominent share of the global pharmaceutical testing and analytical services market in 2019. The expansion of the segment can be attributed to a surge in focus of biopharmaceutical companies on expansion, shifting fixed costs to variable costs, and incorporation of technological advances in their research process, which is highly cost intensive. These factors are fueling the outsourcing of the research & development process, thereby boosting the segment.
North America to Dominate Global Pharmaceutical Testing and Analytical Services Market
The global pharmaceutical testing and analytical services market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pharmaceutical testing and analytical services market in 2019. It was followed by Europe. The U.S. dominated the market in North America, owing to the presence of major market players, significant healthcare expenditure, and increase in research activities across the region. Robust expansion of the market in the region can be attributed to increase in the number of clinical trials and a rise in the demand for biosimilars owing to patent expiry, which fuels the demand for rapid conduction of trials and regulatory approvals. This, in turn, fuels the demand for analytical testing from pharmaceutical manufacturers and consequently boosts the market.
The pharmaceutical testing and analytical services market in Asia Pacific is anticipated to expand at a rapid rate from 2020 to 2030.
Competition Landscape
The global pharmaceutical testing and analytical services market is fragmented in terms of number of players. Key players operating in the global market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc, RD Laboratories, Inc., WuXi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma.
Market Segmentation
By Service Type
By End User
By Region
Scope of the Report
VRR’s report on the global pharmaceutical testing and analytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2027. The report provides revenue of the global pharmaceutical testing and analytical services market for the period 2018–2027, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical testing and analytical services market from 2020 to 2030.
The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical testing and analytical services market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical testing and analytical services market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pharmaceutical testing and analytical services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharmaceutical testing and analytical services market.
The report delves into the competition landscape of the global pharmaceutical testing and analytical services market. Key players operating in the global pharmaceutical testing and analytical services market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharmaceutical testing and analytical services market profiled in this report.
Key Questions Answered in Pharmaceutical Testing and Analytical Services Market Report
Research Objectives and Research Approach
The comprehensive report on the global pharmaceutical testing and analytical services market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global pharmaceutical testing and analytical services market in terms of service type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical testing and analytical services market.
Table of Contents
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast
4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Clinical Trials Analysis
5.3. Covid-19 Impact Analysis
6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
6.1. Introduction
6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
6.3.1. Bioanalytical Testing
6.3.1.1. Cell-Based Assays
6.3.1.2. Virology Testing
6.3.1.3. Others
6.3.2. Method Development & Validation
6.3.2.1. Extractables & Leachables Method Development & Validation
6.3.2.2. Stability-indicating Method Validation
6.3.2.3. Process Impurity Method Development & Validation
6.3.2.4. Others
6.3.3. Raw Material Testing
6.3.3.1. Heavy Metal Testing
6.3.3.2. Complete Compendial Testing
6.3.3.3. Others
6.3.4. Stability Testing
6.3.4.1. Drug Substance Stability Testing
6.3.4.2. Formulation Evaluation Stability Testing
6.3.4.3. Others
6.3.5. Microbial Testing
6.3.5.1. Microbial Limit Testing
6.3.5.2. Sterility Testing
6.3.5.3. Endotoxin Testing
6.3.5.4. Others
6.3.6. Others
6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
7.1. Introduction
7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical & Biopharmaceutical Companies
7.3.3. Others
7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region
8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region
8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region
8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
9. North America Pharmaceutical Testing and Analytical Services Market Analysis
9.1. North America Pharmaceutical Testing and Analytical Services Market Overview
9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country
9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country
9.3.1. U.S.
9.3.2. Canada
9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
9.5.1. Bioanalytical Testing
9.5.1.1. Cell-Based Assays
9.5.1.2. Virology Testing
9.5.1.3. Others
9.5.2. Method Development & Validation
9.5.2.1. Extractables & Leachables Method Development & Validation
9.5.2.2. Stability-indicating Method Validation
9.5.2.3. Process Impurity Method Development & Validation
9.5.2.4. Others
9.5.3. Raw Material Testing
9.5.3.1. Heavy Metal Testing
9.5.3.2. Complete Compendial Testing
9.5.3.3. Others
9.5.4. Stability Testing
9.5.4.1. Drug Substance Stability Testing
9.5.4.2. Formulation Evaluation Stability Testing
9.5.4.3. Others
9.5.5. Microbial Testing
9.5.5.1. Microbial Limit Testing
9.5.5.2. Sterility Testing
9.5.5.3. Endotoxin Testing
9.5.5.4. Others
9.5.6. Others
9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
9.7.1. Medical Devices Companies
9.7.2. Pharmaceutical & Biopharmaceutical Companies
9.7.3. Others
10. Europe Pharmaceutical Testing and Analytical Services Market Analysis
10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview
10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
10.5.1. Bioanalytical Testing
10.5.1.1. Cell-Based Assays
10.5.1.2. Virology Testing
10.5.1.3. Others
10.5.2. Method Development & Validation
10.5.2.1. Extractables & Leachables Method Development & Validation
10.5.2.2. Stability-indicating Method Validation
10.5.2.3. Process Impurity Method Development & Validation
10.5.2.4. Others
10.5.3. Raw Material Testing
10.5.3.1. Heavy Metal Testing
10.5.3.2. Complete Compendial Testing
10.5.3.3. Others
10.5.4. Stability Testing
10.5.4.1. Drug Substance Stability Testing
10.5.4.2. Formulation Evaluation Stability Testing
10.5.4.3. Others
10.5.5. Microbial Testing
10.5.5.1. Microbial Limit Testing
10.5.5.2. Sterility Testing
10.5.5.3. Endotoxin Testing
10.5.5.4. Others
10.5.6. Others
10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
10.7.1. Medical Devices Companies
10.7.2. Pharmaceutical & Biopharmaceutical Companies
10.7.3. Others
11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis
11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview
11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
11.3.1. Japan
11.3.2. China
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
11.5.1. Bioanalytical Testing
11.5.1.1. Cell-Based Assays
11.5.1.2. Virology Testing
11.5.1.3. Others
11.5.2. Method Development & Validation
11.5.2.1. Extractables & Leachables Method Development & Validation
11.5.2.2. Stability-indicating Method Validation
11.5.2.3. Process Impurity Method Development & Validation
11.5.2.4. Others
11.5.3. Raw Material Testing
11.5.3.1. Heavy Metal Testing
11.5.3.2. Complete Compendial Testing
11.5.3.3. Others
11.5.4. Stability Testing
11.5.4.1. Drug Substance Stability Testing
11.5.4.2. Formulation Evaluation Stability Testing
11.5.4.3. Others
11.5.5. Microbial Testing
11.5.5.1. Microbial Limit Testing
11.5.5.2. Sterility Testing
11.5.5.3. Endotoxin Testing
11.5.5.4. Others
11.5.6. Others
11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
11.7.1. Medical Devices Companies
11.7.2. Pharmaceutical & Biopharmaceutical Companies
11.7.3. Others
12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis
12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview
12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
12.5.1. Bioanalytical Testing
12.5.1.1. Cell-Based Assays
12.5.1.2. Virology Testing
12.5.1.3. Others
12.5.2. Method Development & Validation
12.5.2.1. Extractables & Leachables Method Development & Validation
12.5.2.2. Stability-indicating Method Validation
12.5.2.3. Process Impurity Method Development & Validation
12.5.2.4. Others
12.5.3. Raw Material Testing
12.5.3.1. Heavy Metal Testing
12.5.3.2. Complete Compendial Testing
12.5.3.3. Others
12.5.4. Stability Testing
12.5.4.1. Drug Substance Stability Testing
12.5.4.2. Formulation Evaluation Stability Testing
12.5.4.3. Others
12.5.5. Microbial Testing
12.5.5.1. Microbial Limit Testing
12.5.5.2. Sterility Testing
12.5.5.3. Endotoxin Testing
12.5.5.4. Others
12.5.6. Others
12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
12.7.1. Medical Devices Companies
12.7.2. Pharmaceutical & Biopharmaceutical Companies
12.7.3. Others
13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis
13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview
13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
13.5.1. Bioanalytical Testing
13.5.1.1. Cell-Based Assays
13.5.1.2. Virology Testing
13.5.1.3. Others
13.5.2. Method Development & Validation
13.5.2.1. Extractables & Leachables Method Development & Validation
13.5.2.2. Stability-indicating Method Validation
13.5.2.3. Process Impurity Method Development & Validation
13.5.2.4. Others
13.5.3. Raw Material Testing
13.5.3.1. Heavy Metal Testing
13.5.3.2. Complete Compendial Testing
13.5.3.3. Others
13.5.4. Stability Testing
13.5.4.1. Drug Substance Stability Testing
13.5.4.2. Formulation Evaluation Stability Testing
13.5.4.3. Others
13.5.5. Microbial Testing
13.5.5.1. Microbial Limit Testing
13.5.5.2. Sterility Testing
13.5.5.3. Endotoxin Testing
13.5.5.4. Others
13.5.6. Others
13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
13.7.1. Medical Devices Companies
13.7.2. Pharmaceutical & Biopharmaceutical Companies
13.7.3. Others
14. Competitive Landscape
14.1. Competition Matrix
14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company
14.3. Company Profile
14.3.1. Eurofins Scientific
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Laboratory Corporation of America Holdings
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. SGS S.A
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Intertek Group plc
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. RD Laboratories, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. WuXi AppTec Co., Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. DYNALABS LLC (Infinity Laboratories)
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. ARL Bio Pharma
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers